The Madrid-based company applies the same approach, training on real-world use cases and production stacks, across both ...
Builds on momentum following appointment of CEO and completion of Phase III clinical trials for PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”) MISSISSAUGA, Ontario--(BUSINESS WIRE)--Evolve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results